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ABSTRACT 
 
The pencil beam scanning (PBS) modality for delivering intensity modulated 
proton radiation therapy is being adopted quickly. Drawing from the dosimetric 
advantages provided by the Bragg Peak, PBS proton therapy has been shown to 
produce dose distributions with improved healthy tissue sparing.    
Although PBS proton therapy is very promising, lung cancer treatment is 
not without its challenges. Rapid tissue density changes and respiratory tumor 
motion present a particularly difficult treatment geometry. The tumor moves 
continuously within the lung as the patient breathes. 
In this project, the dose perturbation of a PBS proton therapy lung plan is 
evaluated and time based models of respiratory cycle and radiation delivery of a 
pencil beam scanning treatment are created. The combined model of the patient 
and machine is referred to as the patient machine time model (PMTM). The PMTM 
is used to calculate the respiration rate at which the treatment machine dose 
delivery and patient respiration rate produce frequency matching (FM).  
Frequency matching between the respiratory cycle and radiation delivery is 
demonstrated to reduce intra-fraction dose perturbation. The use of the PMTM to 
produce FM provides an advanced tool to mitigate respiratory dose perturbation 
with minimal impact on the patient or the treatment delivery time.  
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CHAPTER ONE 
CONTRIBUTIONS AND BACKGROUND INFORMATION 
 
Problem Statement 
 
During the past two years, the treatment of thoracic tumors with proton therapy 
has shown promise due to increased availability of pencil beam scanning proton 
therapy treatment machines. Pencil beam scanning (PBS) proton therapy 
treatment plans have demonstrated reduced dose to healthy tissue in treatment of 
lung cancer with radiation therapy. Although the dose distribution of proton therapy 
treatment plans is promising, the radiation dose is susceptible to perturbation from 
respiratory motion.  
This dissertation attempts to develop a model of the dose perturbation resulting 
from respiratory motion based on the dose delivery of the treatment machine and 
the respiration cycle of the patient. The model is termed the patient machine time 
model (PMTM). Once the dose perturbation has been evaluated, a dose 
perturbation mitigation method is developed to provide minimal impact to the 
patient.  The developed dose perturbation mitigation method is termed frequency 
matching (FM).  
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Contributions of this Dissertation 
This dissertation makes contributions in the field of radiation therapy specific to 
respiratory motion and pencil beam scanning proton therapy. A patient machine 
time model (PMTM) has never been applied to the treatment planning process in 
proton radiation therapy. A new method to mitigate radiation dose perturbation 
from respiratory motion, frequency matching (FM), is also presented. These 
contributions, and others, are listed below with a detailed explanation located in 
Chapter 3.  
 
1) Development of a model using machine specific parameters to establish 
the dose delivery time for pencil beam scanning proton treatment fields 
delivered by an isochronous cyclotron based radiation therapy machine. 
2) Development of methods to calculate the delivery time of a pencil beam 
scanning layer definition (PLD) file included in the treatment plan of a 
proton therapy treatment.  
3) Development of methods to establish the corresponding respiratory 
amplitude during the delivery of each energy layer of a proton treatment 
field. 
4) Application of the PMTM to reduce dose perturbation by establishing FM 
between the dose delivery and respiration cycle.  
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Organization of the Dissertation 
 
This dissertation is organized into five chapters. Chapter 1 outlines the 
contributions to the field of study as well background information relevant to the 
topic of proton therapy and respiratory motion. Chapter 2 provides a literature 
review of the investigation of respiratory motion and proton therapy dose delivery. 
Chapter 3 includes the description of the data used to build the patient machine 
time model. Chapter 4 provides the results and discussion of the application of the 
patient machine time model (PMTM). Chapter 5 concludes the dissertation and 
discusses the future work related to this research. 
 
Project Description 
 
This project was undertaken to produce a patient machine time model in order to 
evaluate dose perturbation from respiratory target motion in radiation therapy. The 
possibility of frequency matching (FM) between the patient’s respiratory motion 
and the dose delivery of pencil beam scanning proton therapy is also discussed. 
This work is significant because it demonstrates the impact of the time scale of the 
dose delivery of the treatment machine on the dose distribution of the delivered 
radiation therapy treatment. The coupling of the machine delivery and patient 
respiratory motion has the potential to reduce uncertainty in radiation therapy. With 
 4 
 
adequate machine characterization, these concepts could be applied to numerous 
radiation therapy machines. 
In radiation therapy, the unit most commonly used to describe the prescribed 
amount of treatment to a target volume is the Gray. Gray is a measure of absorbed 
energy per unit mass or Joules per Kilogram. This unit is convenient for much of 
radiation therapy because a significant fraction of the human body is of very similar 
density to water, allowing easy scaling and conversion between volume and mass. 
Photon based radiation therapy has been established as the most prevalent form 
of external beam treatment in cancer therapy. Proton therapy has been expanding 
rapidly over the past few years due to the promise provided by the Bragg peak 
produced by the depth dose curve of a proton beam. Figure 1.1 displays the depth 
dose curves of both an 8 Megavoltage (MV) photon beam and a 200 Megaelectron 
Volt (MeV) proton beam [1]. Both the Pristine Bragg peak and Spread Out Bragg 
peak (SOBP) formed from the addition of multiple smaller Bragg peaks are shown.  
Notice that the photon beam produces significantly more entrance dose along its 
path to the tumor depth, while the proton beam produces a peak in the dose at the 
tumor depth. Another feature of the proton beam depth dose curve is that there is 
no significant dose beyond the distal edge of the Bragg peak. In comparison, even 
though the photon beam experiences exponential attenuation, the photon depth 
dose curve still demonstrates significant exit dose. An example of photon and 
proton based radiation therapy plans with multiple fields is discussed below.  
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Figure 1.1. Depth dose of proton and photon beams [1] 
 
Lung Cancer Treatment with Proton Therapy 
 
Lung cancer is one of the most common cancers in both men and women. 
According to the American Cancer Society, about 14% of all cancer cases will be 
lung cancer cases, resulting in almost 225,000 new lung cancer cases in 2016 [2].  
Both photon and proton radiation therapy are often used to treat lung cancer.  
There is growing interest in proton therapy use in lung cancer treatments due to 
its improved dose distribution. The improved dose distribution treats less healthy 
tissue, such and the heart and the opposite lung.  Figure 1.2 displays the dose 
distributions of a proton therapy lung treatment plan on the left and a photon based 
treatment plan on the right [3].  The proton plan utilizes three treatments fields 
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while the photon plan is based on an intensity modulated arc referred to as 
volumetric arc therapy (VMAT). The distributions of these two treatment plans 
provide an interesting comparison between the modalities because they subtend 
a similar fraction of the 360° available treatment arc. 
In Figure 1.2, the heart is located in the center of the axial CT slice. The dose 
distribution displayed in the figure shows a range of dose from 63 Gray shown in 
Red, 30 Gray in green, and everything below 20 Gray displayed in blue. It is 
important to take note of the increased dose to the heart and lungs shown by the 
photon plan in the right side of the figure. 
 
 
Figure 1.2. Dose distribution of three field pencil beam scanning proton and 
volumetric arc therapy photon lung treatments [3] 
 
Figure 1.3 demonstrates the dose to the internal clinical target volume (ICTV) 
along with several other organs at risk (OARs), such as the heart and remainder 
of the lung [3]. The internal gross tumor volume (IGTV) designates the location of 
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the tumor expanded to include the entire respiration cycle motion. 
Notice the significant reduction in dose to healthy organs shown by the proton 
dose. More than 20% of the heart received 20 Gray with the photon plan but the 
proton plan spared almost all of the heart from reaching this dose level. The dose 
to the heart is shown by the red dotted line and the dose to the lung by the black 
dotted line. 
 
 
Figure 1.3. Dose volume histogram (DVH) of proton and photon treatments [3] 
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Proton Therapy Delivery 
 
Uniform Scanning and Double Scattering 
There are three types of proton dose deliveries: double scattering (DS), uniform 
scanning (US), and pencil beam scanning (PBS). Both DS and US create a uniform 
dose cube which is then modified with an aperture and compensator to match the 
tumor shape. The dose distribution produced by DS and US delivery techniques is 
shown in Figure 1.4 [1].  Notice that the high dose profile maintains the same 
square width in depth even though the tumor does not have this full width at the 
lateral edges of the field. These dose tails are the remnants of the original 
distribution of dose being in the shape of a cube.  
In order to conform the dose distribution to the distal edge of the tumor, the cube 
of dose is deformed by the aperture and compensator. The aperture cuts the field 
down to the cross sectional area of the target and the compensator contours the 
dose to the distal edge of the target. The piece labeled 1 in the compensator is the 
inverse of the depth of the distal edge of the tumor. The compensator is thinner 
where the distal edge of target area is deepest and thinner where the distal edge 
is shallower. The second piece of the compensator is used to compensate for the 
curvature of the patient, and it is thicker where the target depth is shallower and 
thinner where the target depth is deeper. The third piece represents additional 
compensator thickness to offset the reduced water equivalent thickness cause by 
the air pocket inhomogeneity.  
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Figure 1.4. Double scattering & uniform scanning proton field dose distribution [1] 
 
Pencil Beam Scanning 
Pencil beam scanning (PBS) proton therapy is a type of treatment delivery that is 
comprised of individual beamlets. Each of these beamlets is deflected to 
transverse to the primary beams direction by scanning magnets in both the X and 
Y directions. In order to match the depth of the distal edge of the target volume the 
energy of the proton beam entering the patient is modulated by an energy degrader 
upstream of the scanning magnets. As the energy of the proton beam entering the 
patient is reduced, its range in the patient is also reduced. Figure 1.5 [1] displays 
the deflection of the proton beam by the scanning magnets to deliver dose to each 
spot on in the tumor, shown in red. 
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Figure 1.5. Pencil beam scanning proton field dose distribution [1] 
 
Treatment Plan Optimization 
PBS proton therapy plans are created with a process known as inverse planning. 
During inverse planning, the dosimetric goals for target coverage and organ 
sparing are given as an optimization problem. The solution to the inverse planning 
problem is solved through an iterative process of recalculating the dose of each 
beamlet in the treatment field until an optimal solution is found. An optimal solution 
occurs at the intersection of the multivariable surface representations of what is 
possible and what is preferable. The surface created by perfect substitution of 
solutions is called a Pareto surface.  A Pareto surface is named after an Italian 
engineer and economist, Vilfredo Pareto, who first presented the concept in the 
field of economics as a country’s production possibilities frontier.  
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Figure 1.6 illustrates a simplified visualization of a multi criteria optimization (MCO) 
problem often used to find solutions for PBS proton therapy treatment plans [4]. 
The optimal solution exists when what is possible intersects the surface of what is 
desirable.  In this example the marginal rate of substitution (MRS) represents the 
surface of the limits of possibility, and the marginal rate of transformation (MRT) 
represents the tradeoffs between what is preferable. In this simplified problem, the 
MRS represents the Pareto surface on which dose to Organ 1 cannot be reduced 
without increasing the dose to Organ 2 and vice versa. The MRT curve represents 
the physician’s preference for substitution between dose to Organ 1 and Organ 2.  
Curves 1 through 4 represent parallel shifts of the trade-off between dose to each 
organ showing increasing utility.  
The preferences represented by this curve would be the clinical goals of the 
physician, ultimately representing an increasingly positive outcome for the patient. 
The intersection of what is possible from a given treatment modality such as PBS 
proton therapy would be represented by the MRS curve. The MRT curve 
represents what is clinically desirable. The intersection of what is possible and 
what is desirable is shown when MRS equals MRT and defines the optimally 
deliverable treatment plan for that modality. The same concepts would be applied 
in photon treatment planning but with a different shape to the MRS curve. 
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Figure 1.6. Simplified Pareto surface from treatment plan optimization [4] 
 
Clinical Proton Therapy Cyclotrons 
 
Many of the proton therapy system in the United States are cyclotron based 
systems. In order to reach the deepest treatment fields most clinical proton therapy 
cyclotrons produce a beam with a final beam energy of at least 230 MeV.  There 
are two types of cyclotrons that are used to produce the proton beams in this 
energy range: isochronous cyclotrons and synchrocyclotrons. The primary 
difference between the two types of cyclotrons is the structure of the magnetic field 
they use to confine the proton beam.  
 13 
 
1) Isochronous cyclotrons consist of a radially increasing magnetic 
field and a constant radio frequency (RF) accelerating voltage 
frequency. This radially increasing magnetic field creates a 
defocusing force which must be compensated by passing the proton 
beam through magnetic poles of alternating strength, call “hills” and 
“valleys”. 
 
2) Synchrocyclotrons use a radially decreasing magnetic field and a 
variable RF accelerating voltage frequency. This radially decreasing 
magnetic field allows for a phenomena called weak focusing. The 
radially decreasing magnetic field reduces the need for the beam to 
pass through magnetic poles of alternating strength but creates the 
need for a variable frequency accelerating RF. 
 
Isochronous Cyclotron 
 
Figure 1.7 displays the magnetic field distribution of an isochronous cyclotron. The 
isochronous cyclotron displayed in Figure 1.7 is a four sector machine, producing 
four “hills” of high strength magnetic field and four “valleys” of reduced strength 
magnetic field [5]. This alternating magnetic field strength produces a restorative 
force, keeping the individual particles within the accelerating plane of the cyclotron.  
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Figure 1.7. Magnetic field distribution of an isochronous cyclotron [5]  
 
As a proton is accelerated to its final extraction energy of over 230 MeV, the 
particle begins to become relativistic and experiences a relativistic mass gain. This 
increase in mass results in a reduced charge-to-mass ratio of the accelerating 
proton. The radially increasing magnetic field of the isochronous cyclotron, shown 
in Figure 1.8, compensates for the relativistic mass gain and keeps the procession 
frequency of the accelerating proton in phase with the RF accelerating voltage from 
the inner orbitals of the cyclotron until the final extraction energy [5]. 
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Figure 1.8. Radially increasing magnetic field isochronous cyclotron [5]  
 
Synchrocyclotron 
 
Synchrocyclotrons use a radially decreasing magnetic field and a variable RF 
accelerating voltage frequency. This radially decreasing magnetic field allows for 
a phenomena called weak focusing, removing the need for the beam to pass 
through magnetic poles of alternating strength. Figure 1.9 [6], displays a vertical 
cross-section of a synchrocyclotron along its rotational axis of symmetry taken 
from a magnetic field simulation in Opera [7]. Opera is a physics simulation 
software that is commonly used to design the magnetic field of particles accelerator 
components such as cyclotrons, dipoles and quadrupoles.  
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Cyclotrons are symmetric rotationally along the vertical axis as well as along the 
mid-plane. This symmetry allows the magnetic field simulation to be simplified to a 
single quadrant. The magnetic field components are used to confine and steer 
charged particles using the Lorenz force, F = q ( v x B ). Where F is the force, q is 
the particle charge, v is the velocity vector, and B is the magnetic field vector. 
The blue volume, shown in Figure 1.9, represents the magnetized steel of the 
cyclotron and the multicolored component represents a cross-section of the 
solenoid coil used to magnetize it [6]. The color gradient in the figure shows the 
magnetic field, B [Tesla], ranging in strength from nearly zero, in blue, to up to over 
5.7 Tesla, in red.  The gradual reduction in the amount of steel during the first 
400mm of distance from the center of the cyclotron is most pronounced between 
the radii of 300 mm and 400 mm. This reduction in steel produced a reduction in 
magnetized material and results in the characteristic radially decreasing magnetic 
field shown in Figure 1.10 [6]. 
Although the magnetic field within a synchrocyclotron is simplified when compared 
to an isochronous machine, the accelerating RF voltage frequency must still be 
matched to the procession frequency of the accelerating protons orbiting in the 
cyclotron. In order to produce an accelerating voltage that is in phase with the 
accelerating proton the RF frequency must be ramped down as the proton reaches 
higher energies and becomes more relativistic. Figure 1.11 demonstrates the ramp 
down of RF accelerating frequency, shown by the blue line between the beam 
capture and beam extraction windows shown in green dotted lines [6].  
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Figure 1.9. Synchrocyclotron cross section with radially decreasing iron [6] 
 
 
Figure 1.10. Radially decreasing synchrocyclotron magnetic field [6]  
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Figure 1.11. Synchrocyclotron radio frequency and beam cycling [6]  
 
The example synchrocyclotron shown in Figure 1.9 would produce a proton beam 
extraction once every millisecond, resulting in a proton pulse frequency of 1 kHz. 
The pulse structure of a synchrocyclotron is much different than an isochronous 
cyclotron which produces proton beam pulses at the same frequency as the 
primary accelerating RF frequency of 50-100 MHz. The isochronous cyclotron 
beam can be treated as a continuous beam because the pulse frequency is 
extremely high. This may not be the case for synchrocyclotrons.  
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CHAPTER TWO 
LITERTURE REVIEW 
  
This section will review the previous work pertaining to respiratory tumor target 
motion and radiation therapy, particularly in the area of lung cancer treatments 
performed with pencil beam scanning (PBS) proton radiation therapy. Several 
other techniques for respiratory target motion mitigation are also reviewed. It 
should be noted that lung cancer treatment with PBS proton therapy is available 
at very few facilities which is why it is of particular interest at this time. 
Respiration Frequency and Amplitude 
The rate at which the patient is breathing along with the distribution of the patients 
inhale and exhale phases are necessary in order to create an accurate model of a 
patient’s respiration. 
 
Respiration Frequency 
Figure 2.1 displays various respiration rates. The most relevant is that of the lying 
respiration rate, “LIE”, at nearly 15 breaths per minute [8]. This respiration rate is 
significant because all of the PBS proton radiation therapy treatments at the 
Provision Center for Proton Therapy (PCPT) are conducting in the lying position, 
with the majority completed with the patient lying on their back. In Figure 2.1, the 
solid line represents a respiratory inductive plethysmograph (RIP) in which the 
respiration rate is measured with a traditional belt potentiometer around the 
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patient’s chest. The dotted line represents an ambulatory inductive 
plethysmograph (AIP) which tracts the respiration rate with a set of sensors on the 
patient’s chest, allowing the patient to have greater mobility.    
 
 
Figure 2.1. Respiration rate during various activities [8] 
 
Amplitude 
Figure 2.2 shows the relationship between the volumetric flow of air through the 
oral cavity and that of the expansion of the chest and movement of the diaphragm 
[9]. Figure 2.3 displays a typical time distribution of the inhale and exhale phases 
of the respiratory cycle  [9]. This distribution was the basis of the distribution used 
to build the patient machine time model presented in Chapter 3.  It is important to 
note that the inhalation of a volume of air precedes the rising of the chest.  
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Figure 2.2. Respiratory amplitude at various locations on the body [9] 
 
 
Figure 2.3. Single respiratory cycle [9]  
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PNT refers to pneumotachograph, which directly measures the airflow rate out of 
the patient’s oral cavity. Body plethysmography (BP) is a measure of the 
respiration volume. Respiratory inductive plethysmography (RIP) is a measure of 
the physical displacement of the rib cage (RC) or the abdomen (ABD). Depending 
on the sensors used to determine the respiratory amplitude a phase lag may need 
to be determined in order to correspond to the respiratory amplitude of the internal 
patient anatomy. 
4D Diagnostic CT Phase Binning 
 
Four dimension computed tomography (4D CT) refers to a computed tomography 
diagnostic scan that is acquired while the respiratory amplitude is recorded. The 
4D CT scan is acquired in all three spatial directions as well as over an extended 
period of time. The forth component, time, creates the four dimensions of a 4D CT.  
During a 4D CT, numerous CT slices of the patient are obtained at multiple 
respiratory amplitudes which are then sorted into full diagnostic quality CT scans 
at all of the respiratory amplitude phases. Figure 2.4 displays the concepts behind 
4D CT binning [10]. The top part of the figure shows the ideal 4D CT acquisition. 
The CT scanner table is held is position long enough to acquire a CT slice at each 
phase of the reparatory cycle and tagged with its corresponding amplitude. The 
bottom of Figure 2.4 shows how the slices at the same respiratory amplitude are 
combined from multiple table positions. This process should provide 10 full CT 
scans of the patient, with one CT scan at each bin of the respiratory amplitude. 
 23 
 
Respiratory Motion in Radiation Therapy 
 
Many methods have been explored to reduce the respiratory motion-induced 
dose uncertainty in spot-scanning proton therapy. Unlike a photon beam, a 
proton beam has a specific depth at which the majority of its dose will be 
delivered. This feature of the proton depth dose allows the potential for greater 
respiratory motion dose perturbation than in a photon field delivery. 
 
Figure 2.4. 4D CT phase binning [10] 
 
 
Lung cancer tumors are often solid masses with a density much closer to water 
than the surrounding lung tissue, which is primarily air. Figure 2.5 displays the path 
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of the tumor, delineated as the clinical tumor volume (CTV), during a respiration 
cycle [11]. In photons the CTV tumor volume is typically expanded to a target 
volume that is large enough to include the full cycle of the tumor motion during 
respiration, marked internal target volume (ITV). The planning target volume 
(PTV), represents the expansion of the ITV for mechanical accuracy of the 
patient’s position in the treatment room coordinate system and any possible 
movement of the patient’s external anatomy.  
 
 
Figure 2.5. Cyclic motion of clinical tumor volume (CTV) [11] 
 
Breath-Hold 
A breath-hold technique can be used in an attempt to deliver the entire radiation 
field in the same respiratory amplitude that the patient is holding their breath. 
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Figure 2.6 shows the promising dosimetric results from a study on voluntary breath 
hold approach to lung treatment delivery [12].  Image (a) of Figure 2.6 shows the 
tight margin around the treatment volume outlined in red provided by the breath 
hold technique. Image (b) displays the larger dose perturbation resulting from a 
treatment field delivery with the patient is free-breathing.  
The primary limitation of breath-hold approach is the short length a patient can 
hold their breath. Patients with lung cancer may already have impaired lung 
function that prevents them from holding their breath for an extended period of 
time. It would be very difficult to use a breath-hold approach for many pencil beam 
scanning lung treatment fields, as many have delivery times that extend well over 
one minute. 
 
Figure 2.6. Breath-hold proton therapy delivery [12]   
 
Gating  
Gating offers an alternative to the breath-hold approach for motion management 
that would allow the patient to continue breathing with their natural respiration rate. 
Figure 2.7 displays a respiratory cycle with a gate at the lowest amplitude section 
of the respiration cycle [13].  The proton beam delivery to the treatment room is 
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controlled by the accelerating voltage within the cyclotron with the IBA 
ProteusPlus. Future proton therapy system may make use of high speed switching 
magnets that will control the beam’s entry into the treatment room. The transition 
from RF manipulation to switching magnets may allow for improvements in beam 
delivery reliability.  
Gating is the most similar to the patient machine time model (PMTM) model and 
frequency matching (FM) described in Chapter 3 and appears very promising. 
Gating is still limited by the quality of the respiration amplitude measurement during 
the treatment field delivery and often requires devices to be attached to the patient 
for each fraction.  
 
 
Figure 2.7. Respiratory gating signal with low amplitude gate window [13] 
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Scanning Modification 
Several methods have been proposed to modify the scanning pattern of the proton 
pencil beam scanning fields to make them less susceptible to respiratory motion. 
Figure 2.8 displays typical dose scanning patterns in frames (a) and (b), moving 
from left to right [14]. Frame (c) displays the modified scanning pattern which 
delivers all of the proton beamlets in the field in a sparser pattern allowing dose to 
be delivered over the entire grid through the respiratory cycle. Another approach 
suggested increasing the spot size  [15], but this would increase the penumbra of 
the field. 
 
 
Figure 2.8. Modified pencil beam scanning pattern [14]  
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CHAPTER THREE 
DEVELOPMENT OF THE PATIENT MACHINE TIME MODEL 
 
This section will describe the parameters that were used to model the time scale 
of the dose delivery from the IBA Proteus Plus proton therapy system located at 
the Provision Center for Proton Therapy (PCPT) in Knoxville Tennessee. The time 
scale of the dose delivery is then overlaid with a typical patient’s respiratory 
amplitude. The PCPT system described in this section makes use of an 
isochronous cyclotron and pencil beam scanning. The PCPT facility floor plan 
shown in Figure 3.1, displays the isochronous cyclotron in the right most bunker, 
represented by a large circular structure [1]. The primary function of analyzing the 
system was to identify the time scale of the dose delivery of proton radiation 
therapy treatment fields. The project was undertaken with the following goals. 
 
1) Model the interval and length of time the proton beam dose is 
delivered within a pencil beam scanning treatment field. 
2) Model the respiratory signal used to create 4D CT scans. 
3) Couple the treatment machine dose delivery frequency and the 
respiratory cycle frequency to establish the patient machine time 
model (PMTM).  
4) Provide information that can be used as input for treatment planning 
and machine delivery to produce frequency matching (FM) between 
the patient’s respiration and treatment machine’s dose delivery.  
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Similar concepts of dose delivery pulse structure could be used to describe other 
systems such as synchrotrons and synchrocyclotrons. Those systems would have 
different mechanisms contributing to the dose delivery time scale. The most 
significant difference between the isochronous cyclotrons and synchronous 
machines is that the pulse structure of the isochronous machine produces a beam 
that at the time scale of the treatment field appears as if it is direct current. For a 
proton therapy system based on an isochroous cyclotron, the only changes in the 
beam delivery are results of the energy degrader and the beam transport system.  
 
 
Figure 3.1. Provision Center for Proton Therapy layout with IBA Proteus Plus 
isochronous cyclotron  [1]  
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Synchronous machines differ from isochronous machines in that these 
accelerators change the frequency of the accelerating voltage to match the kinetic 
energy and relativistic correction of the accelerating protons. After the proton beam 
reaches its final energy it is extracted and transported down the beamline. In order 
to deliver additional protons another bunch of protons must be injected into the 
accelerator and the accelerating voltage frequency reset to match the initial energy 
of the beam. The accelerating voltage is then ramped up again to match the beam 
energy and relativistic corrections. Creating a model of the time structure of dose 
delivery for synchronous accelerators would require additional parameters. 
 
Proton PBS Treatment Field Specification  
 
This section describes the parameters of the radiation fields that are sent to the 
IBA proton therapy treatment machine from the treatment planning system. These 
files are stored in an Oncology information system (OIS) and later transferred to 
the treatment machine for patient alignment and radiation delivery. 
In order to deliver a pencil beam scanning proton treatment, several pieces of data 
are transferred to the treatment machines. The transferred data is comprised of a 
computed tomography x-ray based scan of the patient, computer generated 
structures to identify organs and target volumes, and the radiation treatment plan. 
The radiation treatment plan for PBS is generated by the treatment planning 
system and includes a spot map file with the energy, location, and amount of 
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monitor units (MU) to be delivered in each spot. This file is referred to as a pencil 
beam scanning layer definition file (PLD). MUs are a unit of measure that are 
proportional to the dose in the patient. MUs are measured by ionization chambers 
in the beam line upstream of the patient. The dose inside the patient in units of 
Gray can be accurately delivered as long as the energy of the proton beam is 
known along with the amount of monitor units delivered. 
Figure 3.2 displays the treatment planning structures created by contouring the 
patient’s autonomy on a diagnostic quality CT scan. The CT scan that is acquired 
is diagnostic quality and used to both identify the tumor target and the organs at 
risk (OARs). In the figure you can see the right lung represented in dark blue, the 
left lung in light blue and the heart in red. The target tumor volume is within the 
dark blue right lung structure.  
 
 
Figure 3.2. Structures representing organs at risk (OARs) 
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Figure 3.3 shows a visual representation of the individual proton beamlets within 
a layer of one field of the treatment plan. The location of the distal edge of the 
beamlets, where most of the dose is delivered, is often referred to as the proton 
beamlet’s “spot”. The individual beamlets within a treatment field layer are all 
delivered at the same energy, in this case 140.5 MeV, shown in the upper left 
corner of Figure 3.3.  
 
 
Figure 3.3. Beam’s eye view of spots intensity and structures outlines 
 
The dose from the spots within the layers is modulated to provide uniform 
composite coverage of the target volume. The dose is modulated by varying the 
amount of MUs that are delivered to each spot. The MUs from each spot are also 
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displayed in Figure 3.3, the highest MU beamlets are represented with the largest 
orange circles while the lower weighted spots shown by small orange circles. The 
lowest MU beamlets are shown by and orange “x”, this is done to indicate their 
location when the relative size of the MU would have been too small to visualize.  
Pencil Beam Scanning Treatment Fields 
Pencil beam scanning (PBS) treatment fields use a pair of electromagnets that 
deflect the beam perpendicular to its path.  One of the magnets scans in the X 
direction and the other in the Y direction. The transverse X and Y location of 
each spot is specified in the treatment field calculated by the treatment planning 
system. These scanning magnets allow the proton beamlets to reach their 
specified location.  The treatment planning system also specifies the amount of 
MUs and the beam energy to deliver each individual spot in the treatment plan. 
Each individual spot’s parameters are specified in the treatment plan within a 
PLD file.  
Treatment Field – Pencil Beam Scanning Layer Definition 
The treatment plan used to determine the IBA proton therapy machine parameters 
and create a beam model is shown in Figure 3.3. The treatment plan was created 
for a tumor target volume in the right lung. The plan is comprised of two posterior 
fields. Figure 3.4 shows the energy layers and spot parameters from one of the 
treatment fields in the plan. The first energy layer in each field’s PLD is at the 
highest energy and all the subsequent energy layers are at sequentially lower 
energies.  
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Figure 3.4. Two field pencil beam scanning proton therapy lung plan 
 
 
Figure 3.5. Field energy layers and spot parameters 
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Table 3.1 shows the parameters extracted from a portion of the first two layers in 
the PLD file. Each energy layer begins with a line that includes the spot tune ID, 
proton beam energy in MeV, total monitor units (MUs), location (X and Y) and the 
number of spots. The proton beam energy at the start of each layer in column two 
is set by the energy degrader.  
The spot tune ID refers to the beam optics being used to transport the beam to the 
treatment isocenter. The spot tune ID of “4” listed in this PLD file is currently the 
only commissioned beam transport tune. Other tunes could be commissioned for 
treatment planning with the IBA system but the current tune of “4” represents the 
minimum spot size.  
At the beginning of the layer and at each individual spot, the total number of MUs 
in each energy layer is listed in the third column of the PLD file. The rows in the 
PLD with zero monitor units represent tuning pulses, used to accurately position 
the beam before the full MUs of the spot are delivered.   
The number of spots in an energy layer is listed at the beginning of each layer. The 
PLD file used by the IBA system indicates double the amount of spots as in the 
treatment planning system because it includes the tuning pulses. Since the amount 
of monitor units delivered in the tuning pulses is negligible they are ignored. For 
the purpose of this model only the nonzero spots were used.  
As shown in Table 3.1, the X and Y locations of the spots in each energy layer are 
listed in the first two columns associated with each individual spot. These locations 
are given in mm and used by the scanning magnets to position the beam for each 
spot.  
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Table 3.1. Pencil beam scanning layer definition file parameters 
 Spot Tune 
ID MeV MU # of Spots 
4 153.0148692 8.347985446 12 
x [mm] y [mm]     
-2.4011037 1.9813852 0 0 
-2.4011037 1.9813852 2.6692247 0 
4.0348783 1.9813852 0 0 
4.0348783 1.9813852 0.10815182 0 
-5.619095 -3.5923386 0 0 
-5.619095 -3.5923386 0.107137136 0 
0.8168872 -3.5923386 0 0 
0.8168872 -3.5923386 1.9492636 0 
-2.4011037 -9.166062 0 0 
-2.4011037 -9.166062 3.4083252 0 
4.0348783 -9.166062 0 0 
4.0348783 -9.166062 0.10588299 0 
4 149.8405041 51.50052154 38 
-15.652689 13.457595 0 0 
-15.652689 13.457595 5.1544304 0 
-12.46921 7.943646 0 0 
-12.46921 7.943646 7.7887125 0 
-6.1022496 7.943646 0 0 
-6.1022496 7.943646 0.10519581 0 
0.26471013 7.943646 0 0 
0.26471013 7.943646 0.106116466 0 
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Measurement of Proton PBS Treatment Field Delivery Time  
 
This section will describe the data used to model the time scale of the dose delivery 
from the IBA ProteusPlus machine at the Provision Center for Proton Therapy 
(PCPT). Parameters were taken both from the treatment planning system 
commissioning data and time measurements from proton therapy field deliveries.  
Figure 3.6 shows the dose rate monitoring device (DCEU) used to measure the 
delivery time of pencil beam scanning layer definition (PLD) files. The DCEU 
generates an audio beep when the dose rate exceeds a preset value. The DCEU 
was set to alert the user at dose rates above 0.5 Gray per minute. In the case of 
pencil beam scanning proton treatment fields, the dose rate exceeds the threshold 
to trigger a beep on the dose rate monitoring unit any time the beam is on.  
Figures 3.7 and 3.8 show the audio recording of both fields from a lung treatment 
plan. The high audio signal corresponds to each energy layer delivery, including 
all of the beamlet spots within the layer.  
 
 
Figure 3.6. Dose rate monitor 
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Figure 3.7. Field 1 - Measured dose delivery 
 
 
 
Figure 3.8. Field 2 - Measured dose delivery 
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Dose Rate Audio Analysis 
 
The proton pencil beam scanning (PBS) treatment field delivery time scale is 
dominated by the amount of time the system requires to change between energy 
layers. Energy changes are much longer than changing between individual spots 
because the energy degrader must be further inserted into the proton beam, to 
reduce the range of the proton beam. After the energy has been reduced for the 
next energy layer, the entire beam line and gantry optics have to be returned to 
match the energy of the treatment layer. Based on the measured dose rate files, 
this process requires about 4.385 seconds.  
 
Energy Switching Time 
 
The most significant factor in modeling the time scale of the proton dose delivery 
of the IBA machine at PCPT is from energy switching time. Figure 3.7 and Figure 
3.8 display audio recordings of the dose rate monitor signal from the secondary 
dose recording device (DCEU) shown in Figure 3.6.  
Figure 3.9 displays the series of Bragg peaks that comprise a pencil beam 
scanning proton therapy field. Each energy layer shown is normalized to the peak 
dose making it easy to discern the range, i.e. water equivalent thickness, of each 
energy layer in the field. All of the fields used to model the proton PBS lung 
treatment fields are delivered with the same structure of higher energy layers 
followed by each subsequent lower energy layer.  
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Figure 3.9. Pencil beam scanning energy layer Bragg peaks  
 
 
The audio recordings from the dose rate monitoring beep were analyzed to 
calculate the amount of time for the IBA system to change between energy layers. 
The audio files were converted into amplitude vectors and analyzed in the forward 
and reverse direction.  
When analyzing the audio files in the forward direction the start time was detected 
when the amplitude exceeded 45% of the maximum audio level. In order to find 
the next energy layer start time, the search was resumed three seconds after the 
start of the last detected layer. In order to calculate the energy layer end time, the 
audio files were analyzed in the reverse direction. The start and end times were 
compared for the field deliveries in the example lung treatment plan. Field 1 
required an average of 4.383 seconds to transition between energy layers and field 
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2 required 4.384 seconds. A value of 4.385 seconds was used in the model of field 
delivery time based on this data.   
 
Interspot Dead Time 
 
Interspot dead time refers to the amount of time it takes for the scanning magnets 
to transition from on spot position in the PLD to another. This dead time was 
calculated in the model to ensure that the length of time for delivery of each layer 
in the measured audio matched the length of time in the audio recording. The 
model provided a close match to the measured dose delivery with an interspot 
dead time of 10 milliseconds. 
 
Monitor Unit Rate Calculation 
 
In order to calculate the time required for each individual spot, the monitor unit 
(MU) rate of the system had to be determined. Once the beam current in amperes 
(Coulomb/sec) was established for each energy in the clinical delivery range it 
could be converted using the stopping power to a dose rate (Gray/sec). After the 
dose rate was established for each energy, the system calibration between MUs 
and dose (cGy) for each energy was used to determine the MU rate at each energy 
(MU/sec).  
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Modeling of Proton PBS Treatment Field Delivery Time 
 
This section describes features of the model used to determine the delivery time 
of a proton PBS treatment field. Individual parameters of a PBS treatment machine 
and pencil beam are evaluated to determine their contribution to the total delivery 
time. These parameters include energy selection system (ESS) efficiency, beam 
current requested, beam energy and range conversion, dose rate and monitor unit 
rate. All of the data was interpolated with a least-squares exponential fit. Fitting the 
data allowed the model to include the full range of values used in PLD field 
specification. The structure of the exponential fit function is shown in Equation 3.1. 
The coefficients A, B, C and D are used to fit the curve to the data. 
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Energy Selection System Efficiency 
The energy selection system (ESS) used in IBA proton therapy equipment is 
located just beyond the cyclotron shown in Figure 3.1. The energy degrader is 
located after the proton beam exits the extraction channel of the cyclotron. The 
proton beam is extracted at a specific radius and magnetic field. This final 
extraction radius results in a final energy of 230 MeV, two thirds the speed of light.  
Figure 3.10 shows the ESS efficiency of the IBA proton system at PCPT. 
3.1 
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Figure 3.10. Energy selection system efficiency 
 
After the proton beam is extracted from the cyclotron, an energy degrader is used 
to reduce the energy of the proton beam from the final cyclotron extraction energy 
down to the specific energy required for each layer within a treatment field.  The 
ratio of beam current extracted from the cyclotron to that transmitted down the 
beam line after the energy degrader and energy selection system is referred to as 
the ESS efficiency. 
At high energies, the ESS efficiency of the PCPT proton therapy installation are 
more comparable to those of the installation at Massachusetts General Hospital 
(MGH), 53% vs 40% at 32cm range,  but efficiency differs significantly at lower 
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energies [16]. The lower energy ESS efficiency at PCPT is improved from the MGH 
data, 2.7% vs 1%. The improved ESS efficiency at PCPT is largely due to an 
updated degrader design. The PCPT degrader makes use of beryllium rather than 
graphite at lower energies, resulting in less scatter and higher ESS transmission 
efficiency.   
 
Beam Current Request 
 
The amount of beam current request from the cyclotron is energy dependent. In 
order to deliver lower energy proton beams to the treatment room, the energy 
degrader must be placed further into the path of the beam. As the protons pass 
through the energy degrader, their energy is reduced and thus their water 
equivalent depth in the patient is also reduced. In addition to reducing the energy 
of the beam the energy degrader also scatters the beam. Some of these scattered 
protons result in too large of an angle to be transported down the beam line.  
To compensate for the loss of proton transmission efficiency, the IBA system 
increases the beam current requested from the cyclotron. This is accomplished by 
increasing the output from the ion source at the center of the ion source. This 
process is known at beam current feedback. Figure 3.11 displays the range of 
beam current requests for different deliveries.  
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Figure 3.11. Beam current request [nA] 
 
Shallow treatment fields, such as treatments close to the skin, may request in 
excess of 200 nA. Deeper treatment fields that require less energy degrader 
insertion, such as prostate treatments, may produce a beam current request of 
less than 50 nA. Figure 3.12 shows the inverse relationship between ESS 
efficiency and beam current requested. This relationship exists to keep the 
downstream beam current in a narrow range to provide stable dose rate 
monitoring.  The beam current delivery at each energy in the treatment field is the 
product of the ESS efficiency multiplied by the beam current requested from the 
cyclotron. 
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Figure 3.12. ESS Efficiency [%] vs Beam current request [nA] 
 
 
Proton Fluence Rate 
 
This section describes the calculation of fluence based on the field delivery 
parameters of the IBA system. Fluence is a measure of the number of protons per 
unit area. The proton fluence rate is calculated across the range of energies used 
in clinical proton radiation therapy. The ESS efficiency, full width half max (FWHM), 
and beam current request parameters were acquired during commissioning and 
during field delivery.  
The beam current requested from the cyclotron is an energy dependent parameter 
specific to the IBA system. The requested beam current varies with energy to 
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ensure that after losses through the ESS and beam transport there is sufficient 
beam current for accurate beam measurement downstream of the energy 
degrader.  
The FWHM is a statistical parameter with a width of 2.355 standard deviations 
taken from a Gaussian distribution of the data.  The FWHM used to provide the 
surface area over which the calculated beam current was delivered. The FWHM 
was measured during the clinical commission of the IBA proton therapy equipment 
at the Provision Center for Proton Therapy (PCPT) [17].  Figure 3.13 displays the 
FWHM of the proton beam at the entrance as a function of energy. The lower 
energies have a larger spot size due to lower energies scattering more in air and 
additional scatter from passing through a thicker part of the degrader.  
 
Conversion Between MeV and Range 
 
Figure 3.14 shows the relationship used to convert data from range in centimeters 
to proton beam energy in megaelectron volts. The conversion was done using 
water equivalent range [18]. 
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Figure 3.13. Full width half max (FWHM) of the proton beam spot vs. energy 
 
 
Figure 3.14. Proton range [cm] to energy [MeV] conversion 
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Dose Rate 
 
This section describes the conversion from beam current to proton fluence rate.  
Proton fluence rate was calculated using the delivery spot size (FWHM), ESS 
efficiency and beam current request. Equation 3.2 refers to the dose rate 
calculation and Equation 3.3 refers to the proton fluence rate. Figure 3.15 shows 
the resulting dose rate in cGy per second resulting from the other parameters such 
as FWHM, beam current, and stopping power. Equation 3.4 shows, the beam 
current used in the dose rate calculation using the product of the beam current 
requested from the cyclotron multiplied by the ESS efficiency. Both ESS efficiency 
and the beam current request are energy dependent. 
 -.-/ = -0-/ -1-" 13		 -.-/ = .45&	67/&		 897:5&;  
 -0-/ = <= ∙ $ -0-/ = >?@&A;&	67/&	 =94/4A5;BC ∙ 5&;5  
 
< = D&7B	*@99&A/	 *5 	
3.2 
3.3 
 50 
 
< = 1EE	1!! ∙ D&7B	*@99&A/	6&F@&5/ *5  -1-" = G755	E/4==HAI	J4K&9 G&L ∙ ;BCI  
3 = -&A5H/: I;BM  
$ = $9&7 = N >OPG2 C 	 ;BC  
= = =94/4A	;ℎ79I&	 *4@?4BS=94/4A  G&L	 = 1.602	×10XYM	Z4@?&5 
 
 
Figure 3.15. Dose rate [cGy/s] vs. energy [MeV] 
 
3.4 
 51 
 
Monitor Unit Rate 
 
The Monitor Unit (MU) rate is the final piece to establish the dose delivery time 
scale from the pencil beam scanning layer definition (PLD) file associate with each 
treatment field.  Figure 3.16 displays the relationship between MU and dose used 
by the treatment planning system to create clinically deliverable treatment fields.  
The relationship between entrance dose and range shown in Figure 3.16 was used 
to convert the dose rate for each spot in each energy layer into monitor units per 
second (MU/s), shown in Figure 3.17. MU/s was the final parameter used to 
calculate the time required for each spot at a given energy.  
 
 
Figure 3.16. Dose [cGy/10MU] vs. range [cm] 
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Table 3.2 lists some of the first spots, interspot dead time, and the first energy 
change to deliver the second energy layer.  The left column represents the time 
in seconds while the right hand column lists the does rate in MU/s. Table 3.2 also 
demonstrates the 4.385 seconds that is required for the machine to transition 
between energy layers.  Notice that each spot’s individual delivery time it is 
extremely short, often much shorter than the 10 millisecond interspot dead time. 
The significant amount of time dedicated to interspot dead time and energy layer 
transitions demonstrates the importance of modeling the machines delivery 
timescale in order to properly represent the resulting does perturbation that 
occurs as result of tumor target motion.  
 
 
Figure 3.17. Monitor unit rate [MU/sec] 
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Table 3.2. Pencil beam scanning layer definition spot, interspot, and layer 
switching time 
 
Time  [secs] 
Dose Rate 
[MU/sec] 
0.000945517 480.8606824 
0.01 0 
0.000225585 480.8606824 
0.01 0 
0.000582868 480.8606824 
0.01 0 
4.385 0 
0.006075084 477.1260972 
0.01 0 
0.017367621 477.1260972 
0.01 0 
0.001507805 477.1260972 
 
 
Model of Respiratory Cycle 
 
Respiratory Cycle Binning During 4D CT 
A 4D CT refers to a computed tomography X-ray based diagnostic scan that is 
acquired over multiple breathing cycles. This allows CT slices to be captured at all 
of the respiratory amplitudes included in a patient’s inhale and exhale. Ultimately 
the respiratory inhale and exhale cycle is broken up into 10 individual computed 
tomography CT scans. Each of these scans is comprised of all the CT slices 
acquired at a certain amplitude during the patient’s inhale or exhale. This results 
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in five inhale CT scans and five exhale CT scans taken in 20% amplitude 
increments. 
 
Respiratory Cycle Approximation 
 
In order to calculate to which respiratory amplitudes the energy layer delivery 
corresponded, a model of the respiratory signal was created. Figure 3.18 displays 
one cycle of the respiratory amplitude produced from a breathing rate of 15 breaths 
per minute. The model that was developed allows for modification of this 
respiration rate, as it will vary from patient to patient. The shape of the respiratory 
cycle model is based on a sine wave shown by the blue part of the curve and an 
exponential decay shown in the orange part of the curve. The relative lengths of 
the inhale and exhale phase are about one third and two thirds, respectively. This 
ratio between the inhale and exhale phases of the respiratory cycle is designed to 
approximate thoracic respiratory motion. [9] 
Figure 3.19 demonstrates the overlay of a 15 breaths per minute respiratory cycle 
with the modeled machine delivery time for treatment field 1 and respiratory 
amplitude during dose delivery. Figure 3.20 displays the corresponding respiratory 
amplitude associated with each energy layer delivery within the treatment field. 
The respiratory amplitude and inhalation or exhalation indication allows the dose 
from each energy layer to be computed on its corresponding phase of the 4D CT 
scan.  
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Figure 3.18. Respiration inhale and exhale 
 
 
Figure 3.19. Field 1 – Modeled respiration and dose delivery 
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Figure 3.20. Field 1 - Layer and respiration intersection 
 
Table 3.3 displays the respiratory amplitude during each energy layer delivery 
along with an indication as to the inhale or exhale component of the respiratory 
cycle.  Once each energy layer of field 1 has been computed on its corresponding 
4D CT phase, the dose from each 4D CT phase can be deformed onto a single 
phase of the 4D CT for evaluation.  
Figure 3.21 demonstrates the overlay of a 15 breaths per minute respiratory cycle 
with the modeled machine delivery time for treatment field 2. Figure 3.22 displays 
the corresponding respiratory amplitude associated with each energy layer 
delivery within the treatment field. 
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Table 3.3. Field 1 - Layer and respiration intersection 
Layer Amplitude In [1] or Ex [-1] 
1 0.17 1 
2 0.47 1 
3 1.00 1 
4 0.60 -1 
5 0.26 -1 
6 0.50 -1 
7 0.79 1 
8 0.32 -1 
9 0.41 -1 
10 0.80 -1 
11 0.35 1 
12 0.17 1 
13 0.66 -1 
 
Table 3.4 displays the respiratory amplitude during each energy layer delivery 
along with an indication as to the inhale or exhale component of the respiratory 
cycle for field 2. In the third column of the Table 3.4, a “1” indicates an inhale 
component of the respiratory cycle and a “-1” indicates an exhale component of 
the respiratory cycle. The respiratory amplitude and inhalation or exhalation 
indication allows the dose from each energy layer to be computed on its 
corresponding phase of the 4D CT scan. Once each energy layer from field 2 has 
been computed on its corresponding CT the composite this delivery can be 
deformed onto a single phase of the 4D CT for evaluation. The summation of the 
deformed dose from field 1 and field 2 gives the composite perturbed dose as 
modeled by the PMTM energy layer and respiratory amplitude intersections. 
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Figure 3.21. Field 2 – Modeled respiration and dose delivery overlay 
 
 
Figure 3.22. Field 2 - Layer and respiration intersection 
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Table 3.4. Field 2 - Layer and respiration intersection 
Layer Amplitude In [1] or Ex [-1] 
1 0.17 1 
2 0.53 1 
3 1.00 1 
4 0.64 -1 
5 0.36 -1 
6 0.20 -1 
7 0.55 1 
8 0.94 -1 
9 0.46 -1 
10 0.24 -1 
11 0.25 1 
12 0.92 1 
13 0.80 -1 
14 0.55 -1 
 
Once the corresponding respiratory amplitude and inhalation or exhalation has 
been determined for each energy layer delivery in both treatment fields each 
energy layer can be recalculated on its corresponding 4D phase. 
 
Frequency Matching 
 
This section demonstrates the potential for frequency matching (FM), which results 
when the respiratory frequency and machine frequency are close enough that all 
of the energy layers are delivered in the same phase of the 4D CT.  
FM could have a significant impact on proton pencil beam scanning (PBS) 
treatment delivery by minimizing the necessity for more cumbersome motion 
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mitigation approaches such as breath hold techniques or machine gating. Based 
on the information from the 4D CT, the treatment plan could be optimized such 
that it is deliverable on any phase of the 4D CT. Once the treatment plan has been 
optimized across all CT phases, FM could be sufficient by itself. This would entail 
measuring the patient’s respiratory rate in the treatment room and matching it to 
the machine delivery rate.  
Figure 3.23 shows the results of field 1 delivered at a respiration rate of 11.8 
breaths per minute. FM allows for all of the energy layers in field 1 to be delivered 
at the same respiratory amplitude.  
Figure 3.24 displays the respiration amplitude at which each of the energy layers 
would be delivered with FM at 11.8 breaths per minute. The plot displays all of the 
energy layer deliveries intersecting the respiratory amplitude on a nearly horizontal 
line. Synchronizing the respiratory rate with the rate at which energy layers are 
delivered allows for FM and an unperturbed dose delivery.   
Table 3.5 displays the respiratory amplitude at each intersection of the energy 
layers in field 1. FM allows for the layers to all be delivered on the same phase of 
the 4D CT. The intersection amplitude ranges from 0.17 to 0.3, normalized to the 
maximum respiratory amplitude. 
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Figure 3.23. Field 1 – Respiration and dose delivery 
 
 
Figure 3.24. Field 1 - Layer and respiration intersection 
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Table 3.5. Field 1 - Layer and respiration intersection 
Layer Amplitude In [1] or Ex [-1] 
1 0.17 1 
2 0.22 1 
3 0.27 1 
4 0.30 -1 
5 0.28 -1 
6 0.26 -1 
7 0.24 1 
8 0.21 -1 
9 0.18 -1 
10 0.17 -1 
11 0.19 1 
12 0.17 1 
13 0.18 -1 
 
Figure 3.25 shows field 2 delivered at a respiration frequency of 12.4 breaths per 
minute. Frequency matching (FM) allows for all of the energy layers in field 2 to be 
delivery at the same respiratory amplitude. Figure 3.26 displays the respiration 
amplitude at which each of the energy layers would be delivered with FM of field 2 
at 12.4 breaths per minute. The increase in the respiration rate to achieve 
frequency matching when comparing field 1 to field 2 is most likely due to field 2 
having one fewer energy layer, 13 vs 14 energy layers and the individual energy 
layers in field 1 being delivered more quickly. When comparing the individual 
energy layers within each treatment field, the longest energy layers in field 1, 
Figure 3.21, are delivered more quickly than in Figure 3.25, field 2, as shown by 
the narrower width of the field 1 energy layers.  
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The plot displays all of the energy layer deliveries intersecting the respiratory 
amplitude on a nearly horizontal line. Synchronizing the respiratory frequency with 
the energy layer delivery allows for FM and an unperturbed dose delivery. Table 
3.6 displays the respiratory amplitude at each intersection of the energy layers in 
field 2. FM at 12.4 breaths per minute allows for the layers to all be delivered on 
the same phase of the 4D CT. The intersection amplitude ranges from 0.17 to 0.22. 
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Figure 3.25. Field 2 - Respiration and dose delivery 
 
 
Figure 3.26. Field 2 - Layer and respiration intersection 
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Table 3.6. Field 2 - Layer and respiration intersection 
Layer Amplitude In [1] or Ex [-1] 
1 0.17 1 
2 0.19 1 
3 0.21 1 
4 0.21 -1 
5 0.22 -1 
6 0.22 -1 
7 0.21 1 
8 0.20 -1 
9 0.18 -1 
10 0.17 -1 
11 0.18 1 
12 0.18 1 
13 0.20 -1 
14 0.23 -1 
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CHAPTER FOUR 
APPLICATION OF THE PATIENT MACHINE TIME MODEL 
 
This section will discuss the results of applying the patient machine time model 
(PMTM) to a two field lung treatment plan that was evaluated with a fifteen 
breathes per minute respiratory rate. The primary purpose of this section is to 
demonstrate the use of the PMTM to evaluate the dose perturbation from 
respiratory motion. Frequency matching (FM) is also shown by matching the 
radiation therapy dose delivery frequency to that of the respiratory frequency.  
In this section the respiratory frequency is modified to synchronize with the 
treatment machines does delivery frequency. The treatment delivery frequency is 
dominated by energy layer switching time with the inter-spot dead time and monitor 
unit (MU) delivery rate serving as secondary effects.  The treatment machine used 
to produce the PMTM currently has a fixed energy layer switching time that is too 
slow to match the respiratory rate of 15 breaths per minute. Another option to 
achieve FM would be to deliver the energy layers at half the respiration rate to 
avoid hitting the energy layer switching rate limit. This should allow for all of the 
energy layers to be delivered on the same phase of the 4D CT but would extend 
the treatment field delivery time significantly.  
Future improvements in technology should allow the energy layer switching time 
to be reduced significantly. If the energy layer switching time were reduced from 
the 4.384 seconds available in the current system configuration to below 3 
seconds, FM could be achieved at the patient’s natural breathing rate. 
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Alternatively, the patient’s respiration frequency could be slowed to match the 
treatment machine’s energy layer delivery frequency. The patient could be 
coached with audio or visual feedback to slow their respiration rate and achieve 
FM.  
Multi Field Optimization Dose Reconstruction 
 
The section describes the application of the patient machine time model (PMTM) 
described in Chapter 3. The model was applied to the following two field treatment 
plan in order to calculate the phases of the 4D CT that each energy layer of dose 
would be delivered on. Figure 4.1 displays the proton pencil beam scanning 
treatment plan calculation on one of the 10 phases of the 4D CT.  This is equivalent 
to the dose distribution achieved by frequency matching (FM).  
Figures 4.2 and Figure 4.3 display the individual dose contributions from each 
treatment field. Each individual beam does not provide uniform tumor cover but 
rather delivers dose in the area where the combine contributions from each 
treatment field produce an optimal dose distribution. The high dose region of field 
1, shown in red, is delivered on the left side of the target volume while the high 
does from field 2 is delivered on the right side of the target volume.  This division 
of target coverage between the two fields can leave the plan more susceptible to 
target volume motion form respiration. 
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Figure 4.1. Two field lung proton plan used for model testing 
 
 
Figure 4.2. Field 1 - Contribution to target coverage using multi field optimization 
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Figure 4.3. Field 2 - Contribution to target coverage using multi field optimization 
 
The treatment plan shown in Figure 4.1 uses multi field optimization (MFO). MFO 
is a technique in which each field does not provide uniform coverage of the target 
volume. Alternatively, a field optimization strategy where each individual beam 
uniformly covers the target volume is known as single field optimization (SFO). An 
MFO approach was selected to evaluate the potential impact of the PMTM in 
treatment cases with respiratory motion. The MFO type of optimization used in this 
example evaluation is not typically applied to targets with respiratory motion 
because it is more susceptible to dose perturbation from respiratory motion.   
Although MFO treatment plans can be more susceptible to dose to respiratory 
motion they are attractive in scenarios requiring more aggressive tissue sparing. 
The PMTM developed in this section may provide additional insight into the 
expansion of MFO to cases with respiratory target motion. 
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Each energy layer of the treatment plan shown in Figure 4.1 will be calculated on 
its corresponding 4D CT phase and deformed back to this phase of the 4D CT. 
The combined dose will provide a representation of the dose delivery as if the 
patient were to breath at 15 breaths per minute. After the composite dose is 
evaluated on a single phase of the 4D CT, the respiratory rate to achieve FM will 
be calculated to represent the delivery of each energy layer on the same phase of 
the 4D CT. 
Figure 4.4 and Figure 4.6 display the respiratory amplitude of each energy layer 
delivery calculated by the PMTM for treatment field 1 and field 2. The respiratory 
rate used in the model was 15 breaths per minute. Figure 4.5 and Figure 4.7 
display the corresponding respiratory amplitude associated with each energy layer 
delivery within the treatment field. Table 4.1 and Table 4.2 display the respiratory 
amplitude during each energy layer. An indication as to the inhale, 1, or exhale, -
1, component of the respiratory cycle is displayed in the third column of the table 
corresponding to each treatment field. The results of the PMTM shown in Table 
4.1 and Table 4.2 were used to calculate the dose from each energy layer onto the 
corresponding phase of the 4D CT.  
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Figure 4.4. Field 1 – Modeled respiration and dose delivery overlay 
 
 
Figure 4.5. Field 1 – Modeled respiration and dose delivery intersection 
 72 
 
Table 4.1. Field 1 - Layer and respiration intersection 
Layer Amplitude In [1] or Ex [-1] 
1 0.17 1 
2 0.54 1 
3 0.99 1 
4 0.68 -1 
5 0.34 -1 
6 0.20 1 
7 0.99 1 
8 0.57 -1 
9 0.30 -1 
10 0.18 -1 
 
 
 
Figure 4.6. Field 2 – Modeled respiration and dose delivery overlay 
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Figure 4.7. Field 2 – Modeled respiration and dose delivery intersection 
 
Table 4.2. Field 2 - Layer and respiration intersection 
Layer Amplitude In [1] or Ex [-1] 
1 0.17 1 
2 0.41 1 
3 0.88 1 
4 0.89 -1 
5 0.44 -1 
6 0.20 -1 
7 0.67 1 
8 0.80 -1 
9 0.39 -1 
10 0.22 -1 
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Multi Field Optimization Dose Perturbation Examination 
 
This section will discuss the resulting dose perturbation of the patient machine time 
model (PMTM) on this two field multi field optimization (MFO) lung treatment plan.  
Using the PMTM and frequency matching (FM) the amount of potential dose 
perturbation cause by the energy layers of a radiation therapy treatment field being 
delivered on numerous different respiratory amplitude can be significantly reduced. 
This section will compare the dose distribution from the composite plan using FM 
and without FM.  
Figure 4.8 displays the dose, without FM, from field 1 and field 2 that was delivered 
onto the full inhale phase of the 4D CT. Figure 4.12 shows the dose from both 
treatment fields as it was delivered onto the Full Inhale phase of the 4D CT. This 
dose distribution displays the result of the energy layers delivered from the 
amplitude and exhale or inhale that corresponds to each 4D CT phase. The dose 
from the energy layers delivered to the remaining phases of the 4D CT are shown 
in the Appendix. The 4D CT phases include: full inhale, 80% inhale, 60% inhale, 
40% inhale, 20% inhale, Full exhale, 20% exhale, 40% exhale, 60% exhale, and 
80% exhale.  
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Figure 4.8. Field 1&2 – Dose delivered to Full Inhale CT phase 
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Figure 4.9 displays the composite dose from the treatment plan when FM is utilized 
to deliver all of the energy layers on the same respiratory amplitude phase of the 
4D CT.  As long as FM is used, is it possible to for all of the energy layers to be 
delivered on the same phase of the 4D CT during an individual fraction within a 
course of treatment.  
Figure 4.10 displays the dose distribution when FM is not used. Notice that the 
tumor dose distribution is perturbed and no longer uniformly convers the target 
volume. This represents the worst case dose perturbation, when the individual 
fields do not full cover the target volume. 
Figure 4.11 displays an axial comparison of the of the dose distribution on the 
phase matched CT in the top section and the dose from each energy layer 
delivered onto the corresponding phase of the 4D CT and then deformed back 
onto the 4D CT phase on which the unperturbed treatment plan was computed. 
Figure 4.12 displays the dose difference between the nominal dose and the 
modeled delivery. The dose distribution shown is the result of the PMTM dose 
subtracted from the unperturbed dose to show the dose difference. This difference 
can be visualized in the plot in Figure 4.13. The dotted line displays the dose on 
the PMTM perturbed delivery and the solid line displays the dose distribution of the 
unperturbed single respiration phase delivery. 
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Figure 4.9. Composite treatment plan dose on Single Phase of 4D CT 
 
 
Figure 4.10. Reconstructed composite treatment plan dose using each energy 
layer’s corresponding 4D CT phase as predicted by the PMTM 
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Figure 4.11. Dose line for comparison of unperturbed dose and patient machine 
time model delivery 
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Figure 4.12. Difference between unperturbed dose and patient machine time 
model delivery 
 
 
Figure 4.13. Difference between nominal dose and modeled perturbed delivery 
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Multi Field Optimization Frequency Matching 
This section displays the use of the patient machine time model (PMTM) on the 
parameters of the two field lung treatment plan shown in Figure 4.1. Figure 4.14 
displays the energy layers and respiratory cycle of field 1 at 12.3 breathes per 
minute, producing frequency matching (FM). FM in field 2 is achieved at 12.4 
breaths per minute, shown in Figure 4.16. As shown previously in Figure 4.13, 
dose perturbation from respiratory motion in multi field optimization (MFO) pencil 
beam scanning (PBS) proton therapy can be significant.  Figure 4.15 and 4.17 
display the amplitude of each energy layers’ delivery achieved by FM. Table 4.3 
and 4.4 display the narrow range of respiratory amplitude intersections of each 
energy layer.   
FM allows the composite dose distribution to remain unperturbed with little 
impact on the patient or treatment delivery time. The dose distribution achieved 
by frequency matching will match the dose distribution of a full treatment delivery 
on a single 4D CT phase. This unperturbed treatment delivery resulting from 
frequency matching is shown in Figure 4.9. 
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Figure 4.14. Field 1 – Predicted frequency matching using the patient machine 
time model 
 
 
Figure 4.15. Field 1 – Respiratory amplitude at each energy layer 
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Table 4.3. Field 1 - Layer and respiration intersection 
Layer Amplitude In [1] or Ex [-1] 
1 0.17 1 
2 0.19 -1 
3 0.22 -1 
4 0.24 -1 
5 0.22 -1 
6 0.19 -1 
7 0.17 -1 
8 0.17 1 
9 0.18 1 
10 0.17 1 
 
 
 
Figure 4.16. Field 2 – Predicted frequency matching using the patient machine 
time model  
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Figure 4.17. Field 2 – Respiratory amplitude at each energy layer 
 
Table 4.4. Field 2 - Layer and respiration intersection 
Layer Amplitude In [1] or Ex [-1] 
1 0.17 1 
2 0.20 -1 
3 0.25 -1 
4 0.28 -1 
5 0.26 -1 
6 0.22 -1 
7 0.19 -1 
8 0.17 -1 
9 0.17 1 
10 0.17 1 
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CHAPTER FIVE 
CONCLUSIONS AND FUTURE WORK 
 
Conclusions 
 
The use of the patient machine time model (PMTM) in pencil beam scanning 
proton therapy could be useful to produce frequency matching (FM) between the 
respiratory frequency of the patient and the dose delivery frequency provided by 
the treatment machine. FM of the respiratory frequency and the machine delivery 
frequency has the potential to mitigate dose perturbation from respiratory target 
motion.  
To achieve FM, it will be important to measure the respiratory rate of the patient 
and match it to the dose delivery rate of the treatment machine. In a frequency 
matched PBS proton therapy delivery, the patient may breathe at 14 breaths per 
minute and the machine may deliver the treatment field at a rate of 14 energy 
layers per minute.  
Future Work 
 
The work in this dissertation has demonstrated the potential for the patient 
machine time model in pencil beam scanning proton radiation therapy. There are 
three key areas for future work to bring frequency matching into clinical practice. 
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1) Measure the patient’s respiration rate at the time of the treatment 
planning simulation 
2) Frequency match the patient’s respiration to the treatment 
machine’s delivery 
3) Frequency match the treatment machine’s delivery to the patient’s 
respiration 
 
A camera based stereoscopic camera system known as No Dose Setup (NDS) 
has also been developed to aid in the reproducibility of patient setup for radiation 
therapy both in CT treatment simulation and in the treatment room. The system is 
currently being used to assist in patient setup as an additional tool, supplementing 
the orthogonal x-rays conventionally used to setup the patient. The system allows 
initial positioning of the patient to be conducted without radiation exposure. The 
NDS system provides real time image fusion between the patient’s current position 
and reference target position.  
A 10 patient 10 fraction study was conducted to compare traditional orthogonal X-
ray patient setup with and without the camera based system. The NDS system 
was used to supplement setup prior to X-ray imaging. The use of the system 
allowed a 23% reduction in the total time the patient stayed in the treatment room 
and eliminated 50% of the X-rays used in the iterative process of setting up the 
patient.  
The NDS system features will be expanded to include respiration rate monitoring 
of the patient from the video stream shown in Figure 5.1. The respiration amplitude 
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of the patient plotted over time is shown in the lower right corner of the NDS user 
interface in Figure 5.1. Significant improvements in respiration motion 
management are expected from the additional surface tracking technology of the 
NDS system. Surface tracking for patient setup and respiratory motion motioning 
should provide improvements in lung cancer treatments both in reduced X-ray 
setup imaging exposure and reduced dose perturbation allowed by frequency 
matching (FM). Continuous respiration rate monitoring of the patient combined with 
dynamic energy layer switching times between 3 and 5 seconds would enable FM 
to become the primary dose perturbation mitigation in pencil beam scanning proton 
therapy. 
Through a collaboration with Oak Ridge National Laboratory (ORNL), Provision 
Center for Proton Therapy (PCPT), and George Washington University (GU), a 
seed grant was awarded to make progress towards adapting proton therapy 
treatment fields to compensate for respiratory motion.  
In order to make strides towards real time motion adaptation one must first acquire 
an accurate representation of the patient’s respiration rate. The first phase of the 
collaboration between ORNL, PCPT, and GU is to develop respiratory rate 
monitoring to supplement the stereoscopic camera based patient setup system. 
Figure 5.1 displays the image fusion produced by the stereoscopic camera system, 
overlaying the patient’s current position and the patient’s previous position. In the 
lower right corner of Figure 5.1 shows the envisioned location of the patient’s 
respiration rate.  
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Figure 5.1. Respiration rate measurement at CT treatment simulation  
 
Once the patient’s respiration rate has been measured, the patient could be 
coached to modify their respiration rate slightly. A slight modification of the 
patient’s respiration rate at the time of the CT simulation combined with the PMTM 
could result in FM of the respiration cycle and dose delivery. 
The final phase would be to utilize modifiable machine delivery parameters to 
produce FM.  This would allow the incorporation of the PMTM into the treatment 
planning optimization. This would also allow optimization of the treatment fields to 
be deliverable on any of the respiratory amplitudes represented in the ten 4D CT 
phases. Along with this optimization, FM would be sufficient to mitigate dose 
perturbation from respiratory motion. 
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In Chapter 4, the model of the multi field optimization dose perturbation makes 
reference to the dose that is predicted to be delivered from the treatment plan on 
each phase of the 4D CT. This Appendix supplements the Figure 4.8 to provide 
the complete set of dose to the corresponding 4D CT phases as predicted by the 
PMTM: full inhale, 80% inhale, 60% inhale, 40% inhale, 20% inhale, Full exhale, 
20% exhale, 40% exhale, 60% exhale, and 80% exhale. Figure 4.10 displays the 
resulting composite treatment plan dose using each of the 4D CT phase shown 
below. 
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Figure A.1. Field 1&2 – Dose delivered to 80% inhale CT phase 
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Figure A.2. Field 1&2 – Dose delivered to 60% inhale CT phase 
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Figure A.3. Field 1&2 – Dose delivered to 40% inhale CT phase 
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Figure A.4. Field 1&2 – Dose delivered to 20% inhale CT phase 
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Figure A.5. Field 1&2 – Dose delivered to full exhale CT phase 
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Figure A.6. Field 1&2 – Dose delivered to 20% exhale CT phase 
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Figure A.7. Field 1&2 – Dose delivered to 40% exhale CT phase 
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Figure A.8. Field 1&2 – Dose delivered to 60% exhale CT phase 
 
 105 
 
 
Figure A.9. Field 1&2 – Dose delivered to 80% exhale CT phase 
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